Intradermal Application of Crotamine Induces Inflammatory and Immunological Changes In Vivo
AbstractCrotamine is a single-chain polypeptide with cell-penetrating properties, which is considered a promising molecule for clinical use. Nevertheless, its biosafety data are still scarce. Herein, we assessed the in vivo proinflammatory properties of crotamine, including its local effect and systemic serum parameters. Sixty male Wistar rats were intradermically injected with 200, 400 and 800 µg crotamine and analyzed after 1, 3 and 7 days. Local effect of crotamine was assessed by determination of MPO and NAG activities, NO levels and angiogenesis. Systemic inflammatory response was assessed by determination of IL-10, TNF-α, CRP, NO, TBARS and SH groups. Crotamine induced macrophages and neutrophils chemotaxis as evidenced by the upregulation of both NAG (0.5–0.6 OD/mg) and MPO (0.1–0.2 OD/mg) activities, on the first and third day of analysis, respectively. High levels of NO were observed for all concentrations and time-points. Moreover, 800 μg crotamine resulted in serum NO (64.7 μM) and local tissue NO (58.5 μM) levels higher or equivalent to those recorded for their respective histamine controls (55.7 μM and 59.0 μM). Crotamine also induced a significant angiogenic response compared to histamine. Systemically, crotamine induced a progressive increase in serum CRP levels up to the third day of analysis (22.4–45.8 mg/mL), which was significantly greater than control values. Crotamine (400 μg) also caused an increase in serum TNF-α, in the first day of analysis (1095.4 pg/mL), however a significant increase in IL-10 (122.2 pg/mL) was also recorded for the same time-point, suggesting the induction of an anti-inflammatory effect. Finally, crotamine changed the systemic redox state by inducing gradual increase in serum levels of TBARS (1.0–1.8 μM/mL) and decrease in SH levels (124.7–19.5 μM/mL) throughout the experimental period of analysis. In summary, rats intradermally injected with crotamine presented local and systemic acute inflammatory responses similarly to histamine, which limits crotamine therapeutic use on its original form. View Full-Text
- Supplementary File 1:
PDF-Document (PDF, 689 KB)
Share & Cite This Article
Silvestrini, A.V.P.; de Macedo, L.H.; de Andrade, T.A.M.; Mendes, M.F.; Pigoso, A.A.; Mazzi, M.V. Intradermal Application of Crotamine Induces Inflammatory and Immunological Changes In Vivo. Toxins 2019, 11, 39.
Silvestrini AVP, de Macedo LH, de Andrade TAM, Mendes MF, Pigoso AA, Mazzi MV. Intradermal Application of Crotamine Induces Inflammatory and Immunological Changes In Vivo. Toxins. 2019; 11(1):39.Chicago/Turabian Style
Silvestrini, Ana V.P.; de Macedo, Luana H.; de Andrade, Thiago A.M.; Mendes, Maíra F.; Pigoso, Acácio A.; Mazzi, Maurício V. 2019. "Intradermal Application of Crotamine Induces Inflammatory and Immunological Changes In Vivo." Toxins 11, no. 1: 39.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.